Literature DB >> 4837435

Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.

K Fuxe, H Corrodi, T Hökfelt, P Lidbrink, U Ungerstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4837435

Source DB:  PubMed          Journal:  Med Biol        ISSN: 0302-2137


× No keyword cloud information.
  22 in total

Review 1.  Classical dopamine agonists.

Authors:  R Horowski; P-A Löschmann
Journal:  J Neural Transm (Vienna)       Date:  2019-02-25       Impact factor: 3.575

2.  Bromocriptine and dopamine receptor stimulation.

Authors:  A G Debono; C D Marsden; P Asselman; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

3.  Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].

Authors:  A C Dolphin; P Jenner; C D Marsden; M C Sawaya
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

4.  Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.

Authors:  J D Parkes; A G Debono; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

5.  Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum.

Authors:  E Laschka; A Herz; J Bläsig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

6.  Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.

Authors:  G M Anlezark; B S Meldrum
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

7.  Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.

Authors:  M T Hyyppä; V A Långvik; U K Rinne
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.

Authors:  J de Belleroche; I M Gardiner
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

10.  On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.